Loading...
Symbols:
Loading...
Symbols:
Sanofi-Aventis (SNY)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Sanofi-Aventis (SNY)
137 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on SNY
- SA Editor Eli Hoffmann(16)
- SA Editor Judith Levy(14)
- Mike Havrilla(8)
- ChinaBio Today(8)
- Centient Biotech Investor(8)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(577)
- David Merkel(403)
- SA Editor Eli Hoffmann(387)
- Andrew Wilkinson(334)
- Richard Shaw(238)
Most commented on authors
- Devin Hobbes(72)
- SA Editor Eli Hoffmann(45)
- David Merkel(20)
- RJ Steffens (13)
- Money Morning (10)
- A Buy & Hold Forever Dividend Stock Portfolio
- Reality Check on the Big Pharma Rumor Mill
- China Bio in Review: Broad Themes and Deals
- Four Biotechs at Attractive Entry Points
- Buffett Likes to Be Early; Don't Rush to Follow
- Generic Drug Industry Outperforms Drug and Healthcare ETFs
- Potential Short Trades on Pending FDA Decisions
- Overview and Analysis of the Global Generic Drug Industry
- RealNetworks Battles Hollywood Studios Over RealDVD
- Ten Healthcare Value Stocks
- Eli Lilly Sinks In After-Hours Trading On Effient Delay
- Pharmaceuticals: Near Term Movers Based On FDA Decision Dates
- Lilly Sinks After Hours on Effient Delay
- What Else Has Buffett Been Buying?
- Wall Street Breakfast: Must-Know News
- Wall Street Breakfast: Must-Know News
- Eli Lilly Moves on News of Its New Bloodthinner
- Yangtze River Delta Developing Huge R&D Base for Drug Companies
- Big Pharma Pipeline: Why So Dry?
- Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
- Hedge Fund Manager's Notebook: Buffet's Buys and the End of the Inflation Trade
- Time to Invest in Pharmaceuticals?
- Four Drug Companies Vying for Diabetes Patients
- Buffett's Berkshire Holdings Doing Well in Q3
- FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen
- Watch for More Coming Biotech Acquisitions
- S&P 500's Best and Worst Net Income Change
- Wall Street Breakfast: Must-Know News
- Wall Street Breakfast: Must-Know News
- Replacement Candidates for David Merkel's Portfolio: From AA to ZZ
- Diabetes Stocks Remain Healthy
- Troubles With Lilly's Effient Empire
- Pfizer Makes a Deal, Wyeth and Elan Release Alzheimer's Drug Results
- Sanofi Makes Offer for Generic Firm Zentiva
- Pfizer on a Respirator - Fast Money Recap (6/18/08)
- Sanofi-Aventis: Play This Low-Risk Combo Along with Buffett
- Wall Street Breakfast: Must-Know News
- ADA's 68th Scientific Sessions: A New Look at Insulin Therapy
- Generics Are Catching Up with Big Pharma
- Immunogen and Seattle Genetics: Verging on an Inflection Point
- Thursday's Options Outlook: DRYS, SNY, YHOO, HNZ, SLE, ALL, SINA, DGL, TIN, CSCO, RIMM
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »